- Home
- Analyse des applications
- DRUGDOCS
- DRUGDOCS Vs. Biosimilar
DRUGDOCS vs Biosimilar Utilisation & Stats
DRUGDOCS® provides health professionals with current, evidence-based information on the drugs they prescribe with direct access to publications.
- Apple App Store
- Gratuit
- Médical
Classement dans le store
- -
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
- Apple App Store
- Payant
- Médical
Classement dans le store
- -
Comparaison des classements DRUGDOCS vs. Biosimilar
Comparez l'évolution du classement de DRUGDOCS au cours des 28 derniers jours à celle de Biosimilar.
Biosimilar#132
Rank
Comparaison des classements DRUGDOCS et Biosimilar par pays
Comparez l'évolution du classement de DRUGDOCS au cours des 28 derniers jours à celle de Biosimilar.
Toutes les catégories
Aucune donnée disponible
Médical
Comparez avec n'importe quel site grâce à notre essai gratuit
DRUGDOCS VS.
Biosimilar
19écembre d, 2024